| 臺大學術典藏 |
2020-07-21T06:09:18Z |
Value of imprint cytology for ultrasound-guided transthoracic core biopsy
|
Wei-Yu Liao;Jerng J.-S.;Chen K.-Y.;Chang Y.-L.;Yang P.-C.;Kuo S.-H.; WEI-YU LIAO; Jerng J.-S.; Chen K.-Y.; Chang Y.-L.; Yang P.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer
|
Yang P.-C.; Chen H.-W.; WEI-YU LIAO; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; Ho C.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L.; Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Dynamics of cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L.; Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee C.-H.;Hsu T.-H.;Wei-Yu Liao;Yang P.-C.;Wang C.-C.;Xiao J.-L.; Lee C.-H.; Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Global expression profiling of theophylline response genes in macrophages: Evidence of airway anti-inflammatory regulation
|
Yao P.-L.;Tsai M.-F.;Lin Y.-C.;Wang C.-H.;Wei-Yu Liao;Chen J.J.W.;Yang P.-C.; Yao P.-L.; Tsai M.-F.; Lin Y.-C.; Wang C.-H.; WEI-YU LIAO; Chen J.J.W.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:16Z |
Using a three-chamber culture chip to study the interactions among cancer cells and two types of stromal cells
|
Lee C.-H.;Hsu T.-H.;Kao Y.-L.;Lin W.-L.;Wei-Yu Liao; Lee C.-H.; Hsu T.-H.; Kao Y.-L.; Lin W.-L.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-07-21T06:09:16Z |
Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chip
|
Lee C.-H.; Hsu T.-H.; Xiao J.-L.; Tsao Y.-W.; Kao Y.-L.; Huang S.-H.; WEI-YU LIAO; Hsu T.-H.;Xiao J.-L.;Tsao Y.-W.;Kao Y.-L.;Huang S.-H.;Wei-Yu Liao;Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:16Z |
Emphysematous gastritis: A deadly infectious disease
|
Huang C.-T.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-07-21T06:09:16Z |
Symptoms, psychological distress, and supportive care needs in lung cancer patients
|
Liao Y.-C.; WEI-YU LIAO; Shun S.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H.; Liao Y.-C.;Wei-Yu Liao;Shun S.-C.;Yu C.-J.;Yang P.-C.;Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:15Z |
Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions
|
Huang C.-T.; Ruan S.-Y.; WEI-YU LIAO; Kuo Y.-W.; Lin C.-Y.; Tsai Y.-J.; Ho C.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Wei-Yu Liao;Jan I.-S.;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; WEI-YU LIAO; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment
|
Lee Y.-H.;Liao Y.-C.;Wei-Yu Liao;Shun S.-C.;Liu Y.-C.;Chan J.-C.;Yu C.-J.;Yang P.-C.;Lai Y.-H.; Lee Y.-H.; Liao Y.-C.; WEI-YU LIAO; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Wei-Yu Liao;Chen J.-H.;Wu M.;Shih J.-Y.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Yu C.-J.; WEI-YU LIAO; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic device
|
Kao Y.-C.;Hsieh M.-H.;Liu C.-C.;Pan H.-J.;Wei-Yu Liao;Cheng J.-Y.;Kuo P.-L.;Lee C.-H.; Kao Y.-C.; Hsieh M.-H.; Liu C.-C.; Pan H.-J.; WEI-YU LIAO; Cheng J.-Y.; Kuo P.-L.; Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study
|
Liao Y.-C.; Shun S.-C.; WEI-YU LIAO; Yu C.-J.; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:12Z |
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
|
Yang P.-C.; Lee C.-H.; Yu C.-J.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Ho C.-C.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-07-21T06:09:12Z |
GM2-activator protein: A new biomarker for lung cancer
|
Potprommanee L.; Ma H.-T.; Shank L.; Juan Y.-H.; WEI-YU LIAO; Chen S.-T.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.; Chen H.-J.; Wu T.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib
|
Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:10Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Keng L.-T.; Lee H.-S.; Chang H.-T.; WEI-YU LIAO; Ho C.-C.; Yu C.-J.; Hsieh S.-C.; Lin C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:10Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Wei-Yu Liao;Yu K.-L.;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yu C.-J.; Yang J.C.H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
Chih-Hsin Yang J.; Yu C.-J.; Ho C.-C.;Wei-Yu Liao;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; Ho C.-C.; WEI-YU LIAO; Lin C.-A.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study
|
Hsieh M.-J.; Wu W.-S.; Chen Y.-M.; Tsai Y.-H.; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; WEI-YU LIAO; Liu C.-Y.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Hsu K.-H.; Yu C.-J.; Yang C.-T.; Tseng C.-H.; Chang G.-C.; Chang G.-C.;Tseng C.-H.;Hsu K.-H.;Yu C.-J.;Yang C.-T.;Chen K.-C.;Yang T.-Y.;Tseng J.-S.;Liu C.-Y.;Wei-Yu Liao;Hsia T.-C.;Tu C.-Y.;Lin M.-C.;Tsai Y.-H.;Hsieh M.-J.;Wu W.-S.;Chen Y.-M. |
| 臺大學術典藏 |
2020-07-21T06:09:08Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:07Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Hsu F.-M.; Yang P.-C.; Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Wei-Yu Liao;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.; Cheng J.C.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Wei-Yu Liao;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:05Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; Yu K.-L.;Tsai T.-H.;Ho C.-C.;Wei-Yu Liao;Lin C.-K.;Hsu C.-L.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:04Z |
Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma
|
Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Hsieh M.-S.; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:04Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer
|
Thress K.; Yang J.C.-H.; Stetson D.; Markovets A.; WEI-YU LIAO; Liao B.-C.; Hsu C.-C.; Hsu C.-C.;Liao B.-C.;Wei-Yu Liao;Markovets A.;Stetson D.;Thress K.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:02Z |
Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells
|
Hou H.-H.;Pan H.-J.;Wei-Yu Liao;Lee C.-H.;Yu C.-J.; Hou H.-H.; Pan H.-J.; WEI-YU LIAO; Lee C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-04-08T10:35:55Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chia-Chi Hsu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James C.-H. Yang; Chong-Jen Yu; Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chong-Jen Yu;James C.-H. Yang;Jin-Yuan Shih;Chia-Chi Lin;Jih-Hsiang Lee;Wei-Hsun Hsu;Bin-Chi Liao;Chia-Chi Hsu;Chen-Tu Wu;Yih-Leong Chang;Kang-Yi Su;Chia-Lin Hsu;Tzu-Hsiu Tsai;Kuan-Yu Chen;Chao-Chi Ho;Wei-Yu Liao;Ching-Yao Yang |
| 臺大學術典藏 |
2020 |
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer
|
Lin W.-C.; Chuang C.-A.; WEI-YU LIAO; Lai C.-F.; Cho S.-L.; Cho S.-L.;Lin W.-C.;Chuang C.-A.;Wei-Yu Liao;Lai C.-F. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2019-03-04T08:13:58Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin, Shu Yung;Yang, Ching Yao;Bin-Chi Liao;Chao-Chi Ho;Wei-Yu Liao;Chen, Kuan-Yu;Tsai, Tzu Hsiu;Chia-Lin Hsu;Hsu, Wei Hsun;Kang-Yi Su;Yih-Leong Chang;Lee, Jih Hsiang;Lin, Chia Chi;Jin-Yuan Shih;Yang, James Chih Hsin;Chong-Jen Yu; Lin, Shu Yung; Yang, Ching Yao; BIN-CHI LIAO; CHAO-CHI HO; WEI-YU LIAO; Chen, Kuan-Yu; Tsai, Tzu Hsiu; CHIA-LIN HSU; Hsu, Wei Hsun; KANG-YI SU; YIH-LEONG CHANG; Lee, Jih Hsiang; Lin, Chia Chi; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T08:10:37Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Lin, Ching Kai;Tsai, Tzu Hsiu;JIN-YUAN SHIH;CHIA-LIN HSU;WEI-YU LIAO;CHAO-CHI HO;KAI-LUN YU; KAI-LUN YU; Tsai, Tzu Hsiu; CHAO-CHI HO; WEI-YU LIAO; Lin, Ching Kai; CHIA-LIN HSU; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:04:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
CHONG-JEN YU; CHAO-CHI HO; WEI-YU LIAO; Lee, Jih Hsing; Tsai, Tzu Hsiu; KANG-YI SU; MIN-SHU HSIEH; YIH-LEONG CHANG; Bai, Ya Ying; Huang, Derek De Rui; Thress, Kenneth S.; CHIH-HSIN YANG; JIN-YUAN SHIH; Lin, Chia Chi; Thress, Kenneth S.;Huang, Derek De Rui;Bai, Ya Ying;Lee, Jih Hsing;Lin, Chia Chi;CHIH-HSIN YANG;YIH-LEONG CHANG;MIN-SHU HSIEH;KANG-YI SU;Tsai, Tzu Hsiu;WEI-YU LIAO;CHAO-CHI HO;CHONG-JEN YU;JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T07:47:57Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Chen, Kuan-Yu;Tsai, Tzu Hsiu;CHONG-JEN YU;JIN-YUAN SHIH;CHAO-CHI HO;WEI-YU LIAO; WEI-YU LIAO; CHAO-CHI HO; Tsai, Tzu Hsiu; Chen, Kuan-Yu; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T07:33:42Z |
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
|
Chang, Gee Chen;Cseh, Agnieszka;Carrière, Philippe;Lorence, Robert M.;Chih-Hsin Yang, James;Unk, Mojca;Spataro, Vito;Gautschi, Oliver;Nechushtan, Hovav;Curioni-Fontecedro, Alessandra;Peters, Solange;WEI-YU LIAO;JIN-YUAN SHIH; Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; JIN-YUAN SHIH; WEI-YU LIAO; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M.; Carri?re, Philippe; Cseh, Agnieszka; Chang, Gee Chen |
| 臺大學術典藏 |
2019-03-04T06:51:46Z |
Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma
|
Yang, Ching-Yao;CHONG-JEN YU;JIN-YUAN SHIH;WEI-YU LIAO;MIN-SHU HSIEH; Yang, Ching-Yao; MIN-SHU HSIEH; WEI-YU LIAO; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T06:50:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang, James Chih Hsin;Lin, Zhong Zhe;Lee, Jih Hsiang;Yang, Ching Yao;Lin, Yen Ting;Chen, Kuan-Yu;CHONG-JEN YU;JIN-YUAN SHIH;CHIA-LIN HSU;CHAO-CHI HO;WEI-YU LIAO;JIN-SHING CHEN; Lin, Yen Ting; JIN-SHING CHEN; WEI-YU LIAO; CHAO-CHI HO; CHIA-LIN HSU; Yang, Ching Yao; Chen, Kuan-Yu; Lee, Jih Hsiang; Lin, Zhong Zhe; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Wei-Yu Liao;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S. |
